首页> 外文OA文献 >The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats

【2h】

The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats

机译：具有全肝细胞癌中血管破坏剂Ca4p治疗性疗效的第一研究，具有全谱分析和血管性：大鼠MRI微臂造影 - 组织病理学的相关性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yewei Liu; Frederik De Keyzer; Yixin Wang; Fengna Wang; Yuanbo Feng; Feng Chen; Jie Yu; Jianjun Liu; Shaoli Song; Johan Swinnen; Guy Bormans; Raymond Oyen; Gang Huang; Yicheng Ni;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats [J] . Liu Yewei, De Keyzer Frederik, Wang Yixin, International Journal of Cancer =: Journal International du Cancer . 2018,第7期

机译：初级肝细胞癌中血管破坏剂Ca4p治疗疗效的第一研究及血管分析及血管性：大鼠MRI微臂造影术 - 组织病理学的相关性
2. Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI [J] . Yewei Liu, Qiu Guan, Xiangyong Kong, Translational Oncology . 2020,第1期

机译：通过肝胆造影剂Mn-DPDP增强MRI预测血管破坏剂CA4P在肝肿瘤大鼠中的治疗功效
3. Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology [J] . Junjie Li, Feng Chen, Yuanbo Feng, Translational Oncology . 2013,第1期

机译：对血管破坏剂Combretastatin A4磷酸的多种反应：肝脏和皮下肿瘤同种异体移植大鼠的MRI生物标志物，微血管造影和组织病理学比较研究。
4. Three-Dimensional Microfluidic Drug Screening Platform to Study Vascularized Hepatocellular Carcinoma in Hypoxic Condition [C] . Jungeun Lim, Hyeri Choi, Noo Li Jeon IEEE International Conference on Micro Electro Mechanical Systems . 2021

机译：三维微流体药物筛查平台研究缺氧条件下血管化肝细胞癌
5. Design and Synthesis of Combretastatin A-1 Analogs, Small Molecule Vascular Disrupting Agents, and Bioreductive Triggers as Potential Therapeutic Agents for the Treatment of Cancer [D] . Nguyen, Benson Lee 2010

机译：Combretastatin A-1类似物，小分子血管分裂剂和生物还原性触发剂作为潜在治疗剂的设计与合成
6. Predicting Therapeutic Efficacy of Vascular Disrupting Agent CA4P in Rats with Liver Tumors by Hepatobiliary Contrast Agent Mn-DPDP-Enhanced MRI [O] . Yewei Liu, Qiu Guan, Xiangyong Kong, 2020

机译：通过肝胆造影剂MN-DPDP增强MRI预测血管破坏剂CA4P在肝肿瘤大鼠大鼠中的治疗疗效
7. Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology [O] . Li Junjie, Chen Feng, Feng Yuanbo, 2013

机译：对血管破坏剂Combretastatin A4磷酸的多种反应：肝脏和皮下肿瘤同种异体移植大鼠的MRI生物标志物，微血管造影和组织病理学比较研究

The first study on therapeutic efficacies of a vascular disrupting agent CA4P among primary hepatocellular carcinomas with a full spectrum of differentiation and vascularity: Correlation of MRI‐microangiography‐histopathology in rats

著录项

相似文献

相关主题

期刊订阅